Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study

Status:
Suspended

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

This registry aims to monitor the safety of Breviscapine Powder-Injection and to identify the potential risk factors for the adverse drug reactions.

Zhong Wang